4.7 Article

A randomized trial of web-based fertility-tracking software and fecundability

Journal

FERTILITY AND STERILITY
Volume 119, Issue 6, Pages 1045-1056

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2023.02.005

Keywords

Key Words; fecundability; fertility; time -to -pregnancy; preconception; randomized trial

Ask authors/readers for more resources

This study assessed the effects of randomization to FertilityFriend.com, a mobile fertility-tracking app, on fecundability. The study found that allocation to FF was associated with higher fecundability. However, these results only applied to participants with specific characteristics.
Objective: To assess the effect of randomization to FertilityFriend.com, a mobile computing fertility-tracking app, on fecundability.Design: Parallel non-blinded randomized controlled trial nested within the Pregnancy Study Online (PRESTO), a North American preconception cohort.Patient(s): Female participants aged 21 to 45 years attempting conception for <= 6 menstrual cycles at enrolment (2013-2019). Intervention: Randomization (1:1) of 5532 participants to receive a premium Fertility Friend (FF) subscription. Main Outcome Measure(s): Fecundability (per-cycle probability of conception). Participants completed bimonthly follow-up questionnaires until pregnancy or a censoring event, whichever came first. We first performed an intent-to-treat analysis of the effect of FF randomization on fecundability. In secondary analyses, we used a per-protocol approach that accounted for adherence in each trial arm. In both analyses, we used proportional probabilities regression models to estimate fecundability ratios (FR) and 95% confidence intervals (CI) comparing those randomized vs. not randomized and applied inverse probability weights to account for loss-to-follow-up (intent-to-treat and per-protocol analyses) and adherence (per-protocol analyses only).Results: Using life-table methods, 64% of the 2775 participants randomized to FF and 63% of the 2767 participants not randomized to FF conceived during 12 cycles; these respective percentages were each 70% among those with 0-1 cycles of attempt time at enrolment. Of those randomized to FF, 72% were defined as adherent (68% of observed menstrual cycles). In intent-to-treat analyses, there was no appreciable association overall (FR = 0.97; 95% CI, 0.90-1.04) or within strata of pregnancy attempt time at enrolment, age, education, or other characteristics. In per-protocol analyses, we observed little association overall (FR = 1.06; 95% CI, 0.99-1.14), but weak-to-moderate positive associations among participants who had longer attempt times at enrolment (FR = 1.15; 95% CI, 0.98-1.35 for 3-4 cycles; FR = 1.14; 95% CI, 0.87-1.48 for 5-6 cycles), were aged <25 years (FR = 1.29; 95% CI, 1.01-1.66), had <= 12 years of education (FR = 1.32; 95% CI, 0.92-1.89), or were non-users of hormonal contraception within 3 months before enrolment (FR = 1.10; 95% CI, 1.02-1.19).Conclusion: No appreciable associations were observed in intent-to-treat analyses. In secondary per-protocol analyses that accounted for adherence, randomization to FF was associated with slightly greater fecundability among selected subgroups of participants; however, these results are susceptible to unmeasured confounding. (Fertil Sterile 2023;119:1045-56. (c) 2023 by American Society for Reproductive Medicine.) El resumen esta disponible en Espanol al final del articulo.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available